Generic placeholder image

Cardiovascular & Hematological Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5257
ISSN (Online): 1875-6182

Beta-Blockers and Nitrates: Pharmacotherapy and Indications

Author(s): Emanuela Facchini, Anna Degiovanni, Chiara Cavallino, Alessandro Lupi, Andrea Rognoni and Angelo S. Bongo

Volume 13, Issue 1, 2015

Page: [25 - 30] Pages: 6

DOI: 10.2174/1871525713666141219114708

Price: $65

Abstract

Many clinically important differences exist between beta blockers. B1-selectivity is of clinical interest because at clinically used doses, b1- selective agents block cardiac b-receptors while having minor effects on bronchial and vascular b-receptors. Beta-adrenergic blocking agents significantly decrease the frequency and duration of angina pectoris, instead the prognostic benefit of beta-blockers in stable angina has been extrapolated from studies of post myocardial infarction but has not yet been documented without left ventricular disfunction or previous myocardial infarction. Organic nitrates are among the oldest drugs, but they still remain a widely used adjuvant in the treatment of symptomatic coronary artery disease. While their efficacy in relieving angina pectoris symptoms in acute settings and in preventing angina before physical or emotional stress is undisputed, the chronic use of nitrates has been associated with potentially important side effects such as tolerance and endothelial dysfunction. B-blockers are the firstline anti-anginal therapy in stable stable angina patients without contraindications, while nitrates are the secondline anti-anginal therapy. Despite 150 years of clinical practice, they remain fascinating drugs, which in a chronic setting still deserve investigation. This review evaluated pharmacotherapy and indications of Beta-blockers and nitrates in stable angina.

Keywords: Angina pectoris, beta-blockers, nitrates, pharmacotherapy, stable angina, vasodilator affect.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy